David Mauleón

2.0k total citations
73 papers, 1.7k citations indexed

About

David Mauleón is a scholar working on Pharmacology, Organic Chemistry and Molecular Biology. According to data from OpenAlex, David Mauleón has authored 73 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 33 papers in Pharmacology, 30 papers in Organic Chemistry and 25 papers in Molecular Biology. Recurrent topics in David Mauleón's work include Inflammatory mediators and NSAID effects (29 papers), Pharmacogenetics and Drug Metabolism (10 papers) and Estrogen and related hormone effects (9 papers). David Mauleón is often cited by papers focused on Inflammatory mediators and NSAID effects (29 papers), Pharmacogenetics and Drug Metabolism (10 papers) and Estrogen and related hormone effects (9 papers). David Mauleón collaborates with scholars based in Spain, Italy and United Kingdom. David Mauleón's co-authors include Germano Carganico, Albert Palomer, Francesc Cabré, Remei Artigas, Juan J. Pérez, María L. García, Jaume Pascual, Francisco Boscá, Miguel A. Miranda and Assumpta Carabaza and has published in prestigious journals such as Journal of Medicinal Chemistry, The Journal of Organic Chemistry and Biochemical Pharmacology.

In The Last Decade

David Mauleón

72 papers receiving 1.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
David Mauleón Spain 25 725 576 368 239 209 73 1.7k
John J. Talley United States 25 1.4k 1.9× 1.8k 3.1× 571 1.6× 158 0.7× 183 0.9× 43 3.1k
Francesc Cabré Spain 18 331 0.5× 327 0.6× 293 0.8× 99 0.4× 139 0.7× 55 995
Krista Laine Finland 26 569 0.8× 178 0.3× 602 1.6× 364 1.5× 92 0.4× 44 2.1k
Marc Ouellet Canada 22 924 1.3× 377 0.7× 399 1.1× 188 0.8× 155 0.7× 37 1.6k
Keiji Kubo Japan 19 145 0.2× 553 1.0× 609 1.7× 65 0.3× 95 0.5× 49 1.9k
Germano Carganico Spain 16 247 0.3× 202 0.4× 216 0.6× 109 0.5× 78 0.4× 40 770
András Váradi Hungary 20 194 0.3× 457 0.8× 738 2.0× 423 1.8× 127 0.6× 60 1.9k
Ming‐Qiang Zhang Netherlands 17 267 0.4× 443 0.8× 590 1.6× 42 0.2× 44 0.2× 45 1.7k
Timothy J. Maziasz United States 15 718 1.0× 320 0.6× 255 0.7× 220 0.9× 67 0.3× 21 1.4k
S. S. Adams United States 16 618 0.9× 166 0.3× 255 0.7× 352 1.5× 89 0.4× 25 1.4k

Countries citing papers authored by David Mauleón

Since Specialization
Citations

This map shows the geographic impact of David Mauleón's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Mauleón with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Mauleón more than expected).

Fields of papers citing papers by David Mauleón

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David Mauleón. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Mauleón. The network helps show where David Mauleón may publish in the future.

Co-authorship network of co-authors of David Mauleón

This figure shows the co-authorship network connecting the top 25 collaborators of David Mauleón. A scholar is included among the top collaborators of David Mauleón based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David Mauleón. David Mauleón is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Palomer, Albert, Jaume Pascual, Mònica Aparici, et al.. (2002). Structure-Based Design of Cyclooxygenase-2 Selectivity into Ketoprofen. Bioorganic & Medicinal Chemistry Letters. 12(4). 533–537. 48 indexed citations
2.
Holzer, Peter, et al.. (2001). Estimation of acute flurbiprofen and ketoprofen toxicity in rat gastric mucosa at therapy-relevant doses. Inflammation Research. 50(12). 602–608. 11 indexed citations
3.
López‐Muñoz, Francisco Javier, et al.. (2000). Analysis of antinociceptive effects of flurbiprofen enantiomers ina rat model of arthritic pain. Methods and Findings in Experimental and Clinical Pharmacology. 22(8). 641–641. 4 indexed citations
4.
Nieto, Ana, et al.. (2000). Intestinal toxicity of ketoprofen-trometamol vs its enantiomers in rat. Role of oxidative stress. Inflammation Research. 49(11). 627–632. 27 indexed citations
5.
Pérez, Juan J., et al.. (1999). Structural basis of the dynamic mechanism of ligand binding to cyclooxygenase. Bioorganic & Medicinal Chemistry Letters. 9(19). 2779–2784. 51 indexed citations
6.
Sebastián, José Vicente Bagán, et al.. (1998). Clinical Comparison of Dexketoprofen Trometamol and Dipyrone in Postoperative Dental Pain. The Journal of Clinical Pharmacology. 38(S1). 55S–64S. 33 indexed citations
7.
Herruzo, Alfonso, et al.. (1998). Comparison of the Efficacy and Tolerability of Dexketoprofen and Ketoprofen in the Treatment of Primary Dysmenorrhea. The Journal of Clinical Pharmacology. 38(S1). 65S–73S. 43 indexed citations
8.
Reuter, Brian K., David Mauleón, & John L. Wallace. (1998). Effects of R‐ and S‐enantiomers of chiral non‐steroidal anti‐inflammatory drugs in experimental colitis. Journal of Gastroenterology and Hepatology. 13(S3). S266–S269. 1 indexed citations
9.
Martín‐Mola, E., Manuel Figueroa, Raimón Sanmartí, et al.. (1998). Comparison of Dexketoprofen Trometamol and Ketoprofen in the Treatment of Osteoarthritis of the Knee. The Journal of Clinical Pharmacology. 38(S1). 74S–80S. 32 indexed citations
10.
Barbanoj, Manel J., Ignasi Gich, Remei Artigas, et al.. (1998). Pharmacokinetics of Dexketoprofen Trometamol in Healthy Volunteers After Single and Repeated Oral Doses. The Journal of Clinical Pharmacology. 38(S1). 33S–40S. 25 indexed citations
11.
Cabré, Francesc, et al.. (1998). Intestinal Ulcerogenic Effect of S(+)‐Ketoprofen in the Rat. The Journal of Clinical Pharmacology. 38(S1). 27S–32S. 12 indexed citations
12.
McGurk, Mark, Paul Robinson, M. De Luca, et al.. (1998). Clinical Comparison of Dexketoprofen Trometamol, Ketoprofen, and Placebo in Dental Pain. The Journal of Clinical Pharmacology. 38(S1). 46S–54S. 34 indexed citations
13.
McGurk, Mark, Philip S. Robinson, Maria De Luca, et al.. (1998). Clinical comparison of dexketoprofen trometamol, ketoprofen, and placebo in postoperative dental pain.. PubMed. 38(S1). 46S–54S. 68 indexed citations
14.
Filizola, Marta, Juan J. Pérez, Albert Palomer, & David Mauleón. (1997). Comparative molecular modeling study of the three-dimensional structures of prostaglandin endoperoxide H2 synthase 1 and 2 (COX-1 and COX-2). Journal of Molecular Graphics and Modelling. 15(5). 290–300. 25 indexed citations
15.
Banfi, Patrizia, et al.. (1995). Synthesis of Alkyl Chain-Modified Ether Lipids and Evaluation of Their in Vitro Cytotoxicity. Journal of Medicinal Chemistry. 38(7). 1216–1228. 5 indexed citations
16.
Boscá, Francisco, Miguel A. Miranda, Germano Carganico, & David Mauleón. (1994). PHOTOCHEMICAL AND PHOTOBIOLOGICAL PROPERTIES OF KETOPROFEN ASSOCIATED WITH THE BENZOPHENONE CHROMOPHORE. Photochemistry and Photobiology. 60(2). 96–101. 128 indexed citations
17.
Cabré, Francesc, et al.. (1993). Synthesis and release of platelet-activating factor and eicosanoids in human endothelial cells induced by different agonists. Inflammation Research. 38(1-2). 212–219. 29 indexed citations
18.
Gutiérrez-Rodrı́guez, Marta, et al.. (1993). Stereoselective cyclooxygenase inhibition in cellular models by the enantiomers of ketoprofen. Chirality. 5(8). 589–595. 60 indexed citations
19.
Cabré, Francesc, et al.. (1992). Antiflammins. Biochemical Pharmacology. 44(3). 519–525. 30 indexed citations
20.
Cabré, Francesc, et al.. (1992). Differential hydrolysis of 1-alkyl-2-acyl and diacylglycerophosphocholines by human and non-human phospholipases A2. Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism. 1124(3). 297–299. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by John J. Talley Breakdown of academic impact, for papers by Francesc Cabré Breakdown of academic impact, for papers by Krista Laine Breakdown of academic impact, for papers by Marc Ouellet Breakdown of academic impact, for papers by Keiji Kubo Breakdown of academic impact, for papers by Germano Carganico Breakdown of academic impact, for papers by András Váradi Breakdown of academic impact, for papers by Ming‐Qiang Zhang Breakdown of academic impact, for papers by Timothy J. Maziasz Breakdown of academic impact, for papers by S. S. Adams
Rankless by CCL
2026